Active	Status	Sponsor type	Region	Phase	Filter
2 Active 4 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Forero, Leonardo
SKB264-II-06, NCT05642780: SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors	Recruiting	2	240	Europe, Canada, US, RoW	SKB264, Pembrolizumab, Keytruda	Klus Pharma Inc., Myriad Genetics, Inc., Discovery Life Sciences, LLC, Ventana Medical Systems, Inc, Frontage Laboratories, Inc.	Solid Tumor	11/26	12/27
PATHFINDER 2, NCT05155605: a Multi-Cancer Early Detection Study	Active, not recruiting	N/A	35885	Canada, US	Multi-Cancer Early Detection Test	GRAIL, Inc.	Early Detection of Cancer, Cancer	02/26	04/28